+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cardiac Point of Care Testing Market by Product (Analyzers, Kits & Assays, Software & Services), Biomarker Type (Cardiac Troponins, CK-MB Fraction, D-Dimer), End-User - Forecast 2024-2030- Product Image
Global Cardiac Point of Care Testing Market by Product (Analyzers, Kits & Assays, Software & Services), Biomarker Type (Cardiac Troponins, CK-MB Fraction, D-Dimer), End-User - Forecast 2024-2030- Product Image
Sale

Global Cardiac Point of Care Testing Market by Product (Analyzers, Kits & Assays, Software & Services), Biomarker Type (Cardiac Troponins, CK-MB Fraction, D-Dimer), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924931
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiac Point of Care Testing Market size was estimated at USD 8.31 billion in 2023, USD 9.38 billion in 2024, and is expected to grow at a CAGR of 13.14% to reach USD 19.74 billion by 2030.

Cardiac point of care testing refers to the bedside or near-patient testing of cardiac patients that facilitates immediate clinical decision-making. This form of diagnostic testing is performed outside of traditional laboratory environments, typically at the time and place of patient care, such as in emergency departments, clinics, ambulance services, or critical care units. The primary goal of cardiac point of care testing is to obtain rapid test results that can be used to assess the condition of a patient's heart, enabling timely and informed treatment interventions. It is often utilized for the detection of biomarkers associated with cardiac events, including myoglobin, homocysteine, and hs C-reactive protein (CRP).

In the rapidly advancing domain of healthcare, the cardiac point of care (POC) testing market is gaining momentum, driven by the escalating need for swift and precise cardiovascular diagnostics. This market is defined by the engineering, manufacturing, and commerce of user-friendly diagnostic instruments and their corresponding reactive agents that facilitate on-site cardiovascular health assessments. These devices, instrumental within acute medical scenarios, cater to a diverse clientele across hospitals, outpatient clinics, and home healthcare. The proliferation of cardiac point of care testing is driven by increasing incidences of cardiovascular diseases among the population, technological strides that promise enhanced diagnostic veracity, and rising global healthcare investment. Despite obstacles such as stringent regulatory frameworks, concerns over diagnostic accuracy, and financial limitations in developing health ecosystems hinder the scope of the global cardiac point of care market. Improvements and robust advancements in cardiac POC testing technologies, including devices and biomarkers to improve testing capabilities, portray promising opportunities for the market vendors.

Regional Insights

In the Americas, the market for cardiac point of care testing continues to display robust growth, driven by the prevalence of cardiovascular diseases, rising healthcare expenditure, and the presence of robust healthcare infrastructure. Additionally, the growth is facilitated by the adoption of cutting-edge technologies, active government initiatives, and the availability of a wide range of products owing to the presence of significant market players. The EMEA region experiences a dynamic market landscape for cardiac point of care testing, where the European market benefits from favorable government policies, a high geriatric population, and an increasing number of initiatives aimed at lowering the burden of cardiovascular diseases.

The Middle East and Africa showcase a growing market due to rising healthcare investments in the Middle Eastern countries and the growing awareness of cardiac health in Africa. The APAC region represents a promising market for cardiac point of care testing, with expectations for the highest growth rate in comparison to the Americas and EMEA. This is attributed to the vast population base, rapidly developing healthcare infrastructure in countries including China and India, and an increase in healthcare spending. Additionally, the region is experiencing a rise in lifestyle-related diseases, including heart conditions, which further propels the demand for quick and efficient diagnostic methods.

Market Trends by Segment

  • Product: Increasing demand for multiplex assays across clinics
  • Biomarker Type: Increasing demand for heart-type fatty acid-binding protein (H-FABP) and ischemia-modified albumin (IMA) for early cardiac detection
  • End-user: Rising usage of cardiac POC testing in diagnostic laboratories for complex systems with high sample capacities

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Hipro Point-of-Care Diagnostics Launched in India

Analyzers are instruments used to detect the presence and concentration of cardiac biomarkers, such as troponin, B-type natriuretic peptide (BNP), and other substances indicative of cardiovascular diseases. The need for analyzers arises when immediate results are critical for diagnosing and managing cardiac conditions, particularly in emergency settings.

Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease

Jana Care Inc. partnered with Roche Diagnostics, to develop and distribute a blood testing platform to enhance remote care for patients with chronic kidney and heart disease. The initial phase of this collaborative effort spotlights the management and surveillance of chronic conditions, specifically chronic kidney disease and heart failure. Aimed at bridging gaps created by geographical and socio-economic barriers, this platform is poised to enhance early detection and consistent monitoring, thereby optimizing the management and mitigation of disease progression.

Cipla expands diagnostics portfolio, launches point-of-care testing device

Cipla Limited has broadened its position in diagnostics with the rollout of Cippoint, a cutting-edge point-of-care testing device. This versatile innovation is engineered to facilitate an expansive array of diagnostic evaluations encompassing cardiac markers, making it particularly vital for rapid cardiac care. Additionally, it serves a multifunctional purpose by enabling the testing for diabetes, a variety of infectious diseases, fertility concerns, thyroid irregularities, inflammation, metabolic markers, and coagulation profiles.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Point of Care Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc. by Zoetis Inc, Abbott Laboratories, ACON Laboratories, Inc., Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Cardiac Insight Inc., CardioGenics Holdings Inc., Chembio Diagnostic Systems, Inc. by Biosynex, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Fujirebio, Horiba, Ltd., I-Sens Inc., LifeSign LLC, Nexus Dx, Inc. by Sinocare, Nova Biomedical, PTS Diagnostics by Danaher Corporation, Quidel Corporation, Radiometer Medical ApS, Randox Laboratories Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trividia Health, Inc.

This research report offers invaluable insights into various crucial aspects of the Cardiac Point of Care Testing Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of cardiovascular disorders among the population
5.1.1.2. Favorable government initiatives for the introduction of POC testing
5.1.1.3. Improving healthcare expenditure across economies worldwide
5.1.2. Restraints
5.1.2.1. Fluctuating cost of materials and components used in cardiac POC testing
5.1.3. Opportunities
5.1.3.1. Improvements and continuous advancements in cardiac POC testing
5.1.3.2. Advances in the development of new biomarkers to improve testing capabilities
5.1.4. Challenges
5.1.4.1. Operational and technical complexities in cardiac POC testing
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing demand for multiplex assays across clinics
5.2.2. Biomarker Type: Increasing demand for heart-type fatty acid-binding protein (H-FABP) and ischemia-modified albumin (IMA) for early cardiac detection
5.2.3. End-user: Rising usage of cardiac POC testing in diagnostic laboratories for complex systems with high sample capacities
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cardiac Point of Care Testing Market, by Product
6.1. Introduction
6.2. Analyzers
6.3. Kits & Assays
6.4. Software & Services
7. Cardiac Point of Care Testing Market, by Biomarker Type
7.1. Introduction
7.2. Cardiac Troponins
7.3. CK-MB Fraction
7.4. D-Dimer
7.5. Heart-Type Fatty Acid-Binding Protein (H-FABP)
7.6. Homocysteine
7.7. hs C-reactive Protein (CRP)
7.8. Ischemia-Modified Albumin (IMA)
7.9. Myoglobin
7.10. Natriuretic Peptides (NPs)
7.11. sCD40L
8. Cardiac Point of Care Testing Market, by End-User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospitals & Clinics
8.4. Research & Academic Institutes
9. Americas Cardiac Point of Care Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cardiac Point of Care Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cardiac Point of Care Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Hipro Point-of-Care Diagnostics Launched in India
12.3.2. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
12.3.3. Cipla expands diagnostics portfolio, launches point-of-care testing device
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. CARDIAC POINT OF CARE TESTING MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC POINT OF CARE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC POINT OF CARE TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CARDIAC POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. CARDIAC POINT OF CARE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CARDIAC POINT OF CARE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY CARDIAC TROPONINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY CARDIAC TROPONINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY CK-MB FRACTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY CK-MB FRACTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY D-DIMER, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY D-DIMER, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HEART-TYPE FATTY ACID-BINDING PROTEIN (H-FABP), BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HEART-TYPE FATTY ACID-BINDING PROTEIN (H-FABP), BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HOMOCYSTEINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HOMOCYSTEINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HS C-REACTIVE PROTEIN (CRP), BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HS C-REACTIVE PROTEIN (CRP), BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ISCHEMIA-MODIFIED ALBUMIN (IMA), BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ISCHEMIA-MODIFIED ALBUMIN (IMA), BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ATRIAL NATRIURETIC PEPTIDE (ANP), BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ATRIAL NATRIURETIC PEPTIDE (ANP), BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE (BNP), BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE (BNP), BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY N-TERMINAL PROBNP (NT-PROBNP), BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY N-TERMINAL PROBNP (NT-PROBNP), BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY SCD40L, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY SCD40L, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 58. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 59. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 76. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 77. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 82. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 83. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 84. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 85. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 90. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 91. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 92. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 93. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 119. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 120. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 121. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 126. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 127. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 128. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 129. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 134. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 135. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 136. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 137. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 138. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 143. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 144. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 145. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 150. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 151. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 152. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 153. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 159. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 160. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 161. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 167. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 168. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 169. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 175. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 176. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 177. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 183. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 184. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 185. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 191. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 192. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 193. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 194. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 195. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 198. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 199. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 200. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 201. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 207. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 208. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 209. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 221. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 224. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 225. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 226. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 227. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 232. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 233. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 234. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 235. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 240. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 241. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 242. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 243. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 248. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 249. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 250. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 251. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 256. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 257. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 258. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 259. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 265. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 266. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 267. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 270. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 271. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 272. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 273. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 274. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 275. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 281. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 282. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 283. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 289. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 290. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 291. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 296. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 297. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 298. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 299. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 300. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 301. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 304. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 305. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 306. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (U

Companies Mentioned

  • Abaxis, Inc. by Zoetis Inc
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cardiac Insight Inc.
  • CardioGenics Holdings Inc.
  • Chembio Diagnostic Systems, Inc. by Biosynex
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio
  • Horiba, Ltd.
  • I-Sens Inc.
  • LifeSign LLC
  • Nexus Dx, Inc. by Sinocare
  • Nova Biomedical
  • PTS Diagnostics by Danaher Corporation
  • Quidel Corporation
  • Radiometer Medical ApS
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trividia Health, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.74 Billion
Compound Annual Growth Rate13.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cardiac PoC Testing Devices Market by Product Type, End User, and Region 2023-2028 - Product Image

Cardiac PoC Testing Devices Market by Product Type, End User, and Region 2023-2028

  • Report
  • 147 Pages
  • Global
From
Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Trends, Recent Developments, Company Profiles - Forecast to 2030 - Product Image

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Trends, Recent Developments, Company Profiles - Forecast to 2030

  • Report
  • 303 Pages
  • Global
From
Global Point of Care Testing Market by Product (Cardio-Metabolic Monitoring Kits, Cholesterol Test Strips, Fertility & Pregnancy Testing Kits), End-User (Ambulatory Care, Home Care, Hospitals or Critical Care) - Forecast 2024-2030 - Product Image

Global Point of Care Testing Market by Product (Cardio-Metabolic Monitoring Kits, Cholesterol Test Strips, Fertility & Pregnancy Testing Kits), End-User (Ambulatory Care, Home Care, Hospitals or Critical Care) - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Cardiac Markers Rapid Tests & POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Cardiac Markers Rapid Tests & POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 48 Pages
  • Global
From
Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Image

Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.